缬沙坦对心力衰竭家兔钙调蛋白依赖性蛋白激酶Ⅱ的影响  被引量:3

Effects of valsartan on myocardial calcium/calmodulin-dependent protein kinase-Ⅱ expression and activity in a rabbit model of heart failure

在线阅读下载全文

作  者:曲辅政[1] 刘志华[1] 蒋彬[1] 邹操[1] 李红霞[1] 韩莲花[1] 蒋文平[1] 

机构地区:[1]苏州大学附属第一医院心内科,215006

出  处:《中华心血管病杂志》2009年第6期501-504,共4页Chinese Journal of Cardiology

基  金:基金项目:江苏省自然科学基金资助项目(BK2005034)

摘  要:目的探讨家兔慢性心力衰竭(心衰)时心肌钙调蛋白依赖性蛋白激酶Ⅱ(CaMKⅡ)蛋白表达及活性的改变及血管紧张素Ⅱ受体拈抗剂缬沙坦长期干预的意义。方法27只家兔随机分为3组,假手术组、心衰组和缬沙坦组各9只,通过超容量负荷联合压力负荷建立家兔心衰模型,于术后7周观察左心室结构、血液动力学的变化及CaMKⅡ的表达和活性的改变。结果与假手术组比较,心衰组左室重量指数(LVMI)、左室舒张末压显著升高(P〈0.05),左室短轴缩短率及左室射血分数明显降低(P〈0.05);与心衰组比较,缬沙坦组左室重量指数、左室舒张末压显著降低(P〈0.05),左室短轴缩短率及左室射血分数明显升高(P〈0.05);心衰组CaMKⅡ蛋白表达及活性显著高于假手术组(P〈0.05);缬沙坦组CaMKⅡ蛋白表达及活性显著低于心衰组(P〈0.05)。结论缬沙坦长期干预心衰,能够改善心脏舒缩功能,可能与其降低CaMKⅡ蛋白表达及活性有关。Objective To investigate the effects of valsartan on myocardial expression and activity of calcium/calmodulin-dependent protein kinase- Ⅱ ( CaMK Ⅱ ) in a rabbit model of heart failure. Methods Rabbits were divided into sham-operated group, heart failure group (volume overload by aortic valve destruction induced aortic insufficiency plus pressure overload induced by abdominal aortic banding) and heart failure plus valsartan ( 20 mg · kg^- 1 · d^-1 , n = 9 each ). Seven weeks later, eehocardiography and hemodynamic examinations were performed and myocardial CaMK Ⅱ expression and activity were detected by Western blot and CaMK Ⅱ activity assay kit, respectively. Results Compared with the sham operated rabbits,left ventricular mass index [ LVMI (3.61 ± 0. 09) g/kg vs. ( 1.32 ± 0. 06) g/kg, P 〈 0. 05 ] and end-diastolic pressure [ LVEDP (23.00 ± 2. 37) mm Hg( 1 mm Hg = 0. 133 kPa) vs. ( - 1.50 ± 0. 5) mm Hg, P 〈 0. 05 ] were significantly increased while left ventrieular shortening fractions [ LVFS ( 17.38 ± 3.13)% vs. (37.83 ±3.58)% , P 〈0. 05] and ejection fraction [LVEF (38.50 ±6.07)% vs. (71.92 ± 4. 56) % , P 〈 0.05 3 were significantly decreased ( all P 〈 0. 05 ) in heart failure rabbits, these changes could be significantly attenuated by valsartan treatment: LVMI [ (2.07 ±0. 14 ) g/kg vs. (3.61 ± 0. 09 ) g/kg, P〈0.05], LVEDP [(2.17 ±0.72) mm Hg vs. (23.00 ±2.37) mm Hg, P〈0. 051, LVFS [(33.83 ±2. 85)% vs. (17.38±3.13)%, P〈0. 05] and LVEF [(64.45 ±3.66)% vs. (38.50± 6. 07)%, P〈0. 05].CaMKⅡ expression (1.45±0.13 vs 0.89±0.05, 1.13±0.12, P〈0.05) and activity [(3.54 ±0. 17)pmol·min^-1·μg^-1 vs. (2. 18 ±0. 13) pmol·min^-1·μg^-1, (2. 79 ±0. 14)pmol·min^-1·μg^-1, p 〈 0. 05 ] in heart failure rabbits were significantly increased than those sham operated rabbits which could be significantly attenuated by valsartan treatment. Conclusion Valsartan improved car

关 键 词:缬沙坦 心力衰竭 充血性 血液动力学 钙(2+)-钙调蛋白依赖性蛋白激酶 

分 类 号:R686[医药卫生—骨科学]

 

参考文献:

正在载入数据...

 

二级参考文献:

正在载入数据...

 

耦合文献:

正在载入数据...

 

引证文献:

正在载入数据...

 

二级引证文献:

正在载入数据...

 

同被引文献:

正在载入数据...

 

相关期刊文献:

正在载入数据...

相关的主题
相关的作者对象
相关的机构对象